Healthcare Technology Featured Article

May 06, 2013

Combination Treatments for Hepatitis Driving Big Revenues


When it comes to battling Hepatitis B and C, there have been some serious drawbacks to the drugs being used for treatment. Whether talking about ineffectiveness or bad side effects, more and more clinical professionals have been looking for new ways to fight off the diseases.

It appears that a combination of different drugs is going to be the way going forward. Frost & Sullivan has recently released a study that showed the revenue generated by markets looking into finding new treatments.

The study, titled “Analysis of European Hepatitis B and C Therapeutics Markets” illustrates that the Hepatitis B market generated as much as $1.26 billion in 2012, and that the market will grow to $1.89 billion by 2019. The Hepatitis C market is looking to become even bigger than that. While that market is currently bringing in revenue that numbers at $2.4 billion, it is expected to grow to about $3.66 billion by 2019.

The side effects associated with the go-to treatment are interferon based, such as fever, headache, muscle and joint pain and others, are driving the search for new combinations of treatments that will be easier on the patients. Wider access to personalized treatment is also forcing medical professionals to come up with varied treatments based on the patient.

Frost & Sullivan Healthcare Research Analyst Deepika Pramod Chopda talked about what their study turned up. "Wider access to national counseling programs and enhancing awareness among high-risk populations such as drug users, infected mothers and migrants is critical. Such initiatives, together with free screening and reduced treatment costs, will help limit the incidence and impact of Hepatitis B and C."

There are treatments out there that have already served to reduce side effects, though with this kind of combination approach, that treatment is a fluid process at the moment.




Edited by Alisen Downey
Get stories like this delivered straight to your inbox. [Free eNews Subscription]




SHARE THIS ARTICLE



FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]